A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Fasting plasma metabolites reflecting meat consumption and their associations with incident type 2 diabetes in two Swedish cohorts




TekijätNoerman Stefania, Johansson Anna, Shi Lin, Lehtonen Marko, Hanhineva Kati, Johansson Ingegerd, Brunius Carl, Landberg Rikard

KustantajaElsevier Inc.

Julkaisuvuosi2024

JournalAmerican Journal of Clinical Nutrition

Tietokannassa oleva lehden nimiThe American journal of clinical nutrition

Lehden akronyymiAm J Clin Nutr

Vuosikerta119

Numero5

Aloitussivu1280

Lopetussivu1292

ISSN0002-9165

eISSN1938-3207

DOIhttps://doi.org/10.1016/j.ajcnut.2024.02.012

Verkko-osoitehttps://doi.org/10.1016/j.ajcnut.2024.02.012

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/387700210


Tiivistelmä

BACKGROUND

Consumption of processed red meat has been associated with increased risk of developing type 2 diabetes (T2D), but challenges in dietary assessment call for objective intake biomarkers.

OBJECTIVES

This study aimed to investigate metabolite biomarkers of meat intake and their associations with T2D risk.

METHODS

Fasting plasma samples were collected from a case-control study nested within Västerbotten Intervention Program (VIP) (214 females and 189 males) who developed T2D after a median follow-up of 7 years. Panels of biomarker candidates reflecting the consumption of total, processed, and unprocessed red meat and poultry were selected from the untargeted metabolomics data collected on the controls. Observed associations were then replicated in Swedish Mammography clinical subcohort in Uppsala (SMCC) (n = 4457 females). Replicated metabolites were assessed for potential association with T2D risk using multivariable conditional logistic regression in the discovery and Cox regression in the replication cohorts.

RESULTS

In total, 15 metabolites were associated with ≥1 meat group in both cohorts. Acylcarnitines 8:1, 8:2, 10:3, reflecting higher processed meat intake [r > 0.22, false discovery rate (FDR) < 0.001 for VIP and r > 0.05; FDR < 0.001 for SMCC) were consistently associated with higher T2D risk in both data sets. Conversely, lysophosphatidylcholine 17:1 and phosphatidylcholine (PC) 15:0/18:2 were associated with lower processed meat intake (r < -0.12; FDR < 0.023, for VIP and r < -0.05; FDR < 0.001, for SMCC) and with lower T2D risk in both data sets, except for PC 15:0/18:2, which was significant only in the VIP cohort. All associations were attenuated after adjustment for BMI (kg/m2).

CONCLUSIONS

Consistent associations of biomarker candidates involved in lipid metabolism between higher processed red meat intake with higher T2D risk and between those reflecting lower intake with the lower risk may suggest a relationship between processed meat intake and higher T2D risk. However, attenuated associations after adjusting for BMI indicates that such a relationship may at least partly be mediated or confounded by BMI.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 20:35